Panacea Biotec Ltd
NSE:PANACEABIO

Watchlist Manager
Panacea Biotec Ltd Logo
Panacea Biotec Ltd
NSE:PANACEABIO
Watchlist
Price: 357.7 INR 4.99%
Market Cap: 21.9B INR
Have any thoughts about
Panacea Biotec Ltd?
Write Note

EV/OCF
Enterprise Value to OCF

-20 269.2
Current
-2.2
Median
6
Industry
Lower than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-20 269.2
=
Enterprise Value
20.3B INR
/
Operating Cash Flow
-1m INR
All Countries
Close
Market Cap EV/OCF
IN
Panacea Biotec Ltd
NSE:PANACEABIO
21.9B INR -20 269.2
FR
Pharnext SCA
OTC:PNEXF
6T USD -236 774.4
US
Abbvie Inc
NYSE:ABBV
299.8B USD 21.3
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 28.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
124.7B USD -125.3
US
Gilead Sciences Inc
NASDAQ:GILD
114.8B USD 10.9
US
Epizyme Inc
F:EPE
94.1B EUR -475.5
AU
CSL Ltd
ASX:CSL
137.3B AUD 35.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
86.2B USD 18.6
US
Seagen Inc
F:SGT
39.3B EUR -74.4
NL
argenx SE
XBRU:ARGX
34B EUR -126
 
IN
Panacea Biotec Ltd
NSE:PANACEABIO
Average EV/OCF: 23
Negative Multiple: -20 269.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -236 774.4
US
Abbvie Inc
NYSE:ABBV
21.3
US
Amgen Inc
NASDAQ:AMGN
28.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -125.3
US
Gilead Sciences Inc
NASDAQ:GILD
10.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -475.5
AU
CSL Ltd
ASX:CSL
35.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.6
US
S
Seagen Inc
F:SGT
Negative Multiple: -74.4
NL
argenx SE
XBRU:ARGX
Negative Multiple: -126

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More